In 2022, the 22-hospital system reported an operating loss of $211.3 million compared with an operating income of $746.3 million in 2021.
Total unrestricted revenues increased 4.5 percent year over year to $13 billion. This is largely attributable to net patient service revenue, which was $11.6 billion in 2022 and $10.9 billion in 2021.
The system’s total expenses increased 13.6 percent year over year to $12.5 billion in 2022. Expenses were up across all categories, with salaries, wages and benefits seeing the biggest increase at 13.8 percent.
Losses from investments in 2022 were $1 billion compared to a gain of $1.4 billion in 2021.
For the three months ended Dec. 31, 2022, Cleveland Clinic reported $290.1 million in net profit and $104.9 million in operating income, compared with $532.8 million in net income and $196.8 million in operating income during the same period in 2021.
Fourth-quarter 2022 revenues were $3.5 billion, up from $3.3 billion the prior year, while expenses hit $3.2 billion, up from $2.9 billion.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
